ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WAI LEE M.D.

Cardiovascular Disease

18,021

$1.27M

1492
1345 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $58

SHANTILAL PATEL M.D.

Cardiovascular Disease

15,449

$625K

1007
880 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$40
Average prescription price

Avg: $58

KRISHNAMOHAN NAMBURI M.D.

Cardiovascular Disease

14,249

$718K

924
792 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $58

RAJENDRA DESAI M.D.

Cardiovascular Disease

13,651

$784K

726
624 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $58

WILLIAM WILSON MD

Cardiovascular Disease

13,327

$548K

2298
1969 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $58

HECTOR MARCHAND M.D.

Cardiovascular Disease

12,651

$978K

670
620 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 24%

$77
Average prescription price

Avg: $58

ARVIND GANDHI M.D.

Cardiovascular Disease

11,605

$672K

707
640 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $58

ROBERT GLASSMAN MD

Cardiovascular Disease

11,514

$723K

739
667 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $58

KEITH ATASSI M.D.

Cardiovascular Disease

11,452

$680K

760
679 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $58

NAWAR MERCHO MD

Cardiovascular Disease

11,308

$580K

815
618 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $58

DAVID GORECKI MD

Cardiovascular Disease

10,607

$494K

611
484 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $58

GEORGE BITTAR MD

Cardiovascular Disease

10,555

$554K

754
633 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $58

ELIAS DALLOUL MD

Cardiovascular Disease

10,532

$411K

646
453 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 24%

$39
Average prescription price

Avg: $58

NEIL KABOUS MD

Cardiovascular Disease

10,369

$454K

626
461 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $58

LAWRENCE RINK M.D.

Cardiovascular Disease

9,949

$557K

572
511 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $58

ADAM DAWKINS MD

Cardiovascular Disease

9,905

$334K

861
760 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 24%

$34
Average prescription price

Avg: $58

DANIEL LINERT M.D.

Cardiovascular Disease

9,222

$497K

578
514 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $58

ROBERT RIDDELL MD

Cardiovascular Disease

9,112

$402K

698
633 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $58

ROBERT GODLEY MD

Cardiovascular Disease

9,045

$481K

844
733 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $58

ARSHAD MALIK MD

Cardiovascular Disease

8,823

$619K

463
374 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $58

JAMES HEGER MD

Cardiovascular Disease

8,584

$429K

841
740 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $58

ROY ROBERTSON MD

Cardiovascular Disease

8,580

$408K

818
700 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $58

NAZZAL OBAID MD

Cardiovascular Disease

8,457

$526K

782
705 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $58

JAMES NEAHRING M.D.

Cardiovascular Disease

8,397

$430K

766
649 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $58

WILLIAM COLLIS MD

Cardiovascular Disease

8,241

$410K

942
805 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $58

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank